200 related articles for article (PubMed ID: 6427954)
1. The physiologic basis of the use of blood and blood products.
Gould SA; Rice CL; Moss GS
Surg Annu; 1984; 16():13-38. PubMed ID: 6427954
[No Abstract] [Full Text] [Related]
2. Optimal use of blood components and derivatives.
Walter WJ; Oberman HA
Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
[No Abstract] [Full Text] [Related]
3. [Therapy-induced hepatitis risk in hemophilia patients].
Schiller WG; Renger FG
Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
[No Abstract] [Full Text] [Related]
4. Blood products.
Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
[No Abstract] [Full Text] [Related]
5. Current status of erythrocyte substitutes.
Biro GP
Can Med Assoc J; 1983 Aug; 129(3):237-44. PubMed ID: 6344974
[TBL] [Abstract][Full Text] [Related]
6. Principles of transfusion medicine perioperatively and in intensive care.
Höcker P
Acta Anaesthesiol Scand Suppl; 1996; 109():137-8. PubMed ID: 8901983
[No Abstract] [Full Text] [Related]
7. Post-transfusion hepatits following the use of prothrombin complex concentrates.
Roberts HR; Blatt PM
Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
[No Abstract] [Full Text] [Related]
8. Selected topics in blood component therapy.
Wallas CH
Prog Clin Pathol; 1984; 9():47-64. PubMed ID: 6420839
[No Abstract] [Full Text] [Related]
9. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation.
Spahn DR; Kocian R
Can J Anaesth; 2003; 50(6 Suppl):S41-7. PubMed ID: 14629052
[No Abstract] [Full Text] [Related]
10. Artificial blood.
Squires JE
Science; 2002 Feb; 295(5557):1002-5. PubMed ID: 11834811
[TBL] [Abstract][Full Text] [Related]
11. [Natural blood and artificial blood in rapid vascular filling].
Courtine JC; Ement AM
Cah Anesthesiol; 1986 May; 34(3):205-7. PubMed ID: 3091206
[No Abstract] [Full Text] [Related]
12. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
[No Abstract] [Full Text] [Related]
13. [Blood affinity for oxygen and blood transfusion].
Bursaux E; Dubos C; Poyart CF
Poumon Coeur; 1971; 27(7):683-9. PubMed ID: 5004223
[No Abstract] [Full Text] [Related]
14. Hazards of blood and blood products. Case report of post-transfusion hepatitis-B.
Wirtz CE; Kirchner JP; Maloney PM
Wis Med J; 1985 May; 84(5):10-1. PubMed ID: 4013365
[No Abstract] [Full Text] [Related]
15. [Indications for blood transfusion].
Hollán Z
Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636
[No Abstract] [Full Text] [Related]
16. Blood substitutes in surgery.
Burris D
Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
[TBL] [Abstract][Full Text] [Related]
17. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
Kessler M; Vogel H; Günther H; Harrison DK; Höper J
Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
[No Abstract] [Full Text] [Related]
18. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
Cohn CS; Cushing MM
Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
[TBL] [Abstract][Full Text] [Related]
19. Post-transfusion hepatitis: analysis of risk factors.
Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
[No Abstract] [Full Text] [Related]
20. Update on alternative oxygen carriers.
Hess JR
Vox Sang; 2004 Jul; 87 Suppl 2():132-5. PubMed ID: 15209897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
